Description
Join us as we review the latest cellular therapy advancements for treatment in the COVID-19 pandemic. In addition to addressing the use of specific T cells in COVID-19 treatment, faculty will also discuss the importance of missing imputation for single cell sequencing (MISC) in COVID-19 analysis.
Learning Objectives:
- Discuss the latest cellular therapies advancements in the COVID-19 pandemic
- Investigate the use of specific T cells in COVID-19 treatment
- Discuss the importance of missing imputation for single cell sequencing (MISC) in COVID-19 analysis
Speaker(s):
Disclosures
- Dusan Bogunovic : Nothing to disclose
- Michael Keller : Consultant: Gilead
